Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Repurposing drugs via network analysis: opportunities for psychiatric disorders
Last weeks JAMA had two articles on GLP-1 drugs that point to their promise for treatment of diseases beyond the conditions for which they are already approved by the FDA: obesity, diabetes, cardiovascular risk, sleep apnea and metabolic liver disease
Archived from the original on 11 July 2022
IGF-1 LR3 is widely used to study cell proliferation and survival mechanisms , particularly in muscle, neural, and epithelial cell lines
Neocryptotanshinone ameliorates insufficient energy production in heart failure by targeting retinoid X receptor alpha
US$ 22.07
US$ 29.47
US$ 21.15
